InvestorsHub Logo
Followers 117
Posts 20166
Boards Moderated 0
Alias Born 06/13/2011

Re: bfost post# 214777

Tuesday, 09/17/2019 12:14:44 PM

Tuesday, September 17, 2019 12:14:44 PM

Post# of 423561
bfost / Duke ...thx for posting . can you read my recent post to JL .

bfost ...What is your interpretation of Clinical ASCVD. My Kaiser Cardiologist is reading that as secondary prevention ( prior event ) only....and will only prescribe as such plus T2 diabetics with 1 additional risk factor ......if FDA approves a label as per NLA statement .

Re some of the other comments by other board readers .
My wife is affiliated with the UC medical system ...UCSF etc ...which is where I'll probably be moving to unless I can get better results from Kaiser.
Kaiser is a lot more convenient for me than UCSF ...but perhaps not if I can't get them to cover Vascepa....especially if they won't cover after FDA approval

bfost ......I would appreciate your interpretation of Clinical ASCVD .....is that only secondary prevention ( ie you had to have had a prior event ) ?
thx
Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News